US Stock MarketDetailed Quotes

Bolt Biotherapeutics (BOLT)

Watchlist
  • 6.676
  • +0.426+6.82%
Trading Jan 23 15:11 ET
12.81MMarket Cap-0.30P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bolt Biotherapeutics (BOLT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
90.10%2.17M
41.49%1.8M
-76.83%1.22M
-2.36%7.69M
0
-54.87%1.14M
-11.03%1.28M
188.83%5.27M
37.48%7.88M
48.05%2.09M
Operating revenue
90.10%2.17M
41.49%1.8M
-76.83%1.22M
-2.36%7.69M
--0
-54.87%1.14M
-11.03%1.28M
188.83%5.27M
37.48%7.88M
48.05%2.09M
Cost of revenue
Gross profit
Operating expense
-43.86%9.87M
-45.76%11.01M
-40.37%13.34M
-9.69%75.93M
-28.30%15.67M
-15.10%17.58M
-4.51%20.31M
10.50%22.37M
-12.47%84.07M
-2.65%21.86M
Selling and administrative expenses
-12.16%3.34M
-27.86%3.52M
-34.47%3.83M
-18.08%18.46M
-28.66%3.95M
-34.05%3.8M
-13.29%4.87M
3.94%5.84M
-1.73%22.53M
-1.30%5.53M
-General and administrative expense
-12.16%3.34M
-27.86%3.52M
-34.47%3.83M
-18.08%18.46M
-28.66%3.95M
-34.05%3.8M
-13.29%4.87M
3.94%5.84M
-1.73%22.53M
-1.30%5.53M
Research and development costs
-52.59%6.54M
-51.42%7.5M
-42.45%9.51M
-6.62%57.47M
-28.18%11.72M
-7.80%13.79M
-1.35%15.43M
13.02%16.53M
-15.84%61.54M
-3.10%16.32M
Operating profit
53.15%-7.7M
51.61%-9.21M
29.12%-12.12M
10.45%-68.24M
20.73%-15.67M
9.57%-16.44M
4.03%-19.03M
7.18%-17.09M
15.64%-76.2M
6.06%-19.77M
Net non-operating interest income expense
-62.35%477K
-57.28%599K
-34.43%1.05M
-24.92%5.26M
-47.40%980K
-34.22%1.27M
-21.01%1.4M
11.92%1.61M
214.84%7M
78.62%1.86M
Non-operating interest income
-62.35%477K
-57.28%599K
-34.43%1.05M
-24.92%5.26M
-47.40%980K
-34.22%1.27M
-21.01%1.4M
11.92%1.61M
214.84%7M
78.62%1.86M
Other net income (expense)
82K
101.40%50K
-99.53%22K
-137K
-1.25M
-3.57M
4.68M
Special income (charges)
--0
--0
----
---4.81M
---1.25M
--0
---3.57M
----
--0
--0
-Less：Restructuring and merger&acquisition
--0
--0
----
--3.34M
---222K
--0
--3.57M
----
--0
--0
-Less:Impairment of capital assets
----
----
----
--1.47M
----
----
----
----
--0
----
Other non- operating income (expenses)
--82K
--50K
-99.53%22K
--4.68M
--0
----
----
--4.68M
----
----
Income before tax
52.93%-7.14M
59.61%-8.56M
-2.12%-11.04M
8.79%-63.12M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.2M
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
Income tax
Net income
52.93%-7.14M
59.61%-8.56M
-2.12%-11.04M
8.79%-63.12M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.2M
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
Net income continuous Operations
52.93%-7.14M
59.61%-8.56M
-2.12%-11.04M
8.79%-63.12M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.2M
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
Minority interest income
Net income attributable to the parent company
52.93%-7.14M
59.61%-8.56M
-2.12%-11.04M
8.79%-63.12M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.2M
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
52.93%-7.14M
59.61%-8.56M
-2.12%-11.04M
8.79%-63.12M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.2M
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
Basic earnings per share
53.09%-3.72
59.89%-4.46
-3.57%-5.8
9.84%-33
10.64%-8.4
7.79%-7.93
-15.83%-11.12
37.78%-5.6
22.46%-36.6
11.32%-9.4
Diluted earnings per share
53.09%-3.72
59.89%-4.46
-3.57%-5.8
9.84%-33
10.64%-8.4
7.79%-7.93
-15.83%-11.12
37.78%-5.6
22.46%-36.6
11.32%-9.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 90.10%2.17M41.49%1.8M-76.83%1.22M-2.36%7.69M0-54.87%1.14M-11.03%1.28M188.83%5.27M37.48%7.88M48.05%2.09M
Operating revenue 90.10%2.17M41.49%1.8M-76.83%1.22M-2.36%7.69M--0-54.87%1.14M-11.03%1.28M188.83%5.27M37.48%7.88M48.05%2.09M
Cost of revenue
Gross profit
Operating expense -43.86%9.87M-45.76%11.01M-40.37%13.34M-9.69%75.93M-28.30%15.67M-15.10%17.58M-4.51%20.31M10.50%22.37M-12.47%84.07M-2.65%21.86M
Selling and administrative expenses -12.16%3.34M-27.86%3.52M-34.47%3.83M-18.08%18.46M-28.66%3.95M-34.05%3.8M-13.29%4.87M3.94%5.84M-1.73%22.53M-1.30%5.53M
-General and administrative expense -12.16%3.34M-27.86%3.52M-34.47%3.83M-18.08%18.46M-28.66%3.95M-34.05%3.8M-13.29%4.87M3.94%5.84M-1.73%22.53M-1.30%5.53M
Research and development costs -52.59%6.54M-51.42%7.5M-42.45%9.51M-6.62%57.47M-28.18%11.72M-7.80%13.79M-1.35%15.43M13.02%16.53M-15.84%61.54M-3.10%16.32M
Operating profit 53.15%-7.7M51.61%-9.21M29.12%-12.12M10.45%-68.24M20.73%-15.67M9.57%-16.44M4.03%-19.03M7.18%-17.09M15.64%-76.2M6.06%-19.77M
Net non-operating interest income expense -62.35%477K-57.28%599K-34.43%1.05M-24.92%5.26M-47.40%980K-34.22%1.27M-21.01%1.4M11.92%1.61M214.84%7M78.62%1.86M
Non-operating interest income -62.35%477K-57.28%599K-34.43%1.05M-24.92%5.26M-47.40%980K-34.22%1.27M-21.01%1.4M11.92%1.61M214.84%7M78.62%1.86M
Other net income (expense) 82K101.40%50K-99.53%22K-137K-1.25M-3.57M4.68M
Special income (charges) --0--0-------4.81M---1.25M--0---3.57M------0--0
-Less：Restructuring and merger&acquisition --0--0------3.34M---222K--0--3.57M------0--0
-Less:Impairment of capital assets --------------1.47M------------------0----
Other non- operating income (expenses) --82K--50K-99.53%22K--4.68M--0----------4.68M--------
Income before tax 52.93%-7.14M59.61%-8.56M-2.12%-11.04M8.79%-63.12M10.99%-15.94M6.65%-15.18M-17.38%-21.2M36.33%-10.81M21.45%-69.2M10.47%-17.9M
Income tax
Net income 52.93%-7.14M59.61%-8.56M-2.12%-11.04M8.79%-63.12M10.99%-15.94M6.65%-15.18M-17.38%-21.2M36.33%-10.81M21.45%-69.2M10.47%-17.9M
Net income continuous Operations 52.93%-7.14M59.61%-8.56M-2.12%-11.04M8.79%-63.12M10.99%-15.94M6.65%-15.18M-17.38%-21.2M36.33%-10.81M21.45%-69.2M10.47%-17.9M
Minority interest income
Net income attributable to the parent company 52.93%-7.14M59.61%-8.56M-2.12%-11.04M8.79%-63.12M10.99%-15.94M6.65%-15.18M-17.38%-21.2M36.33%-10.81M21.45%-69.2M10.47%-17.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 52.93%-7.14M59.61%-8.56M-2.12%-11.04M8.79%-63.12M10.99%-15.94M6.65%-15.18M-17.38%-21.2M36.33%-10.81M21.45%-69.2M10.47%-17.9M
Basic earnings per share 53.09%-3.7259.89%-4.46-3.57%-5.89.84%-3310.64%-8.47.79%-7.93-15.83%-11.1237.78%-5.622.46%-36.611.32%-9.4
Diluted earnings per share 53.09%-3.7259.89%-4.46-3.57%-5.89.84%-3310.64%-8.47.79%-7.93-15.83%-11.1237.78%-5.622.46%-36.611.32%-9.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.59%
Sample Name
Sample Code
 +2.45%
Sample Name
Sample Code
 +2.42%
4
Amazon
AMZN
+2.18%
5
Clean Energy Fuels
CLNE
+1.97%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.56%
Sample Name
Sample Code
 +8.03%
Sample Name
Sample Code
 +4.61%
4
KE Holdings
BEKE
+4.33%
5
New Oriental
EDU
+3.45%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -